Elk-3 Is a Transcriptional Repressor of Nitric-oxide Synthase 2*
暂无分享,去创建一个
M. Layne | S. yet | Yen-Hsu Chen | S. Chung | R. Baron | M. Perrella | K. Ejima
[1] M. Layne,et al. Modulation of the thioredoxin system during inflammatory responses and its effect on heme oxygenase-1 expression. , 2002, Antioxidants and Redox Signaling.
[2] A. Sharrocks,et al. The ETS Domain Transcription Factor Elk-1 Contains a Novel Class of Repression Domain , 2002, Molecular and Cellular Biology.
[3] M. Watanabe,et al. Upstream Stimulatory Factors Regulate Aortic Preferentially Expressed Gene-1 Expression in Vascular Smooth Muscle Cells* , 2001, The Journal of Biological Chemistry.
[4] T. Libermann,et al. ESE-1 Is a Novel Transcriptional Mediator of Inflammation That Interacts with NF-κB to Regulate the Inducible Nitric-oxide Synthase Gene* , 2001, The Journal of Biological Chemistry.
[5] R. Reeves,et al. Down-regulation of High Mobility Group-I(Y) Protein Contributes to the Inhibition of Nitric-oxide Synthase 2 by Transforming Growth Factor-β1* , 2001, The Journal of Biological Chemistry.
[6] R. Maki,et al. Transcription Factor PU.1 Is Necessary for Development of Thymic and Myeloid Progenitor-Derived Dendritic Cells1 , 2000, The Journal of Immunology.
[7] B. Wasylyk,et al. Net, a negative Ras‐switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de‐acetylation , 1999, The EMBO journal.
[8] M. Titheradge. Nitric oxide in septic shock. , 1999, Biochimica et biophysica acta.
[9] O. Griffith,et al. Mammalian nitric oxide synthases. , 1999, Advances in enzymology and related areas of molecular biology.
[10] B. Wasylyk,et al. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. , 1998, Trends in biochemical sciences.
[11] S. Moncada,et al. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse , 1998, British journal of pharmacology.
[12] R. Bone,et al. Sepsis: a new hypothesis for pathogenesis of the disease process. , 1997, Chest.
[13] B. Wasylyk,et al. Net (ERP/SAP2) one of the Ras‐inducible TCFs, has a novel inhibitory domain with resemblance to the helix‐loop‐helix motif. , 1996, The EMBO journal.
[14] Y. Ono,et al. Molecular cloning of Elk-3, a new member of the Ets family expressed during mouse embryogenesis and analysis of its transcriptional repression activity. , 1996, DNA and cell biology.
[15] C. Patterson,et al. Suppression of Interleukin-1β-induced Nitric-oxide Synthase Promoter/Enhancer Activity by Transforming Growth Factor-β1 in Vascular Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.
[16] C. Lowenstein,et al. Arrest of endotoxin-induced hypotension by transforming growth factor beta1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. Bernstein,et al. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes , 1995, Molecular and cellular biology.
[18] R. Treisman,et al. Comparative analysis of the ternary complex factors Elk‐1, SAP‐1a and SAP‐2 (ERP/NET). , 1995, The EMBO journal.
[19] C. Meisel,et al. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta , 1995, The Journal of experimental medicine.
[20] Carl Nathan,et al. Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.
[21] B. Wasylyk,et al. Net, a new ets transcription factor that is activated by Ras. , 1994, Genes & development.
[22] J. Tsai,et al. Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. , 1994, The Journal of biological chemistry.
[23] T. Libermann,et al. ERP, a new member of the ets transcription factor/oncoprotein family: cloning, characterization, and differential expression during B-lymphocyte development , 1994, Molecular and cellular biology.
[24] J. Parrillo. Pathogenetic mechanisms of septic shock. , 1993, The New England journal of medicine.
[25] M. Sporn,et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[26] G. Proetzel,et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.
[27] F. Murad,et al. Induced RAW 264.7 macrophages express soluble and particulate nitric oxide synthase: inhibition by transforming growth factor-beta. , 1992, European journal of pharmacology.
[28] R. Bone,et al. The pathogenesis of sepsis. , 1991, Annals of internal medicine.
[29] M. Sporn,et al. Deactivation of macrophages by transforming growth factor-β , 1988, Nature.
[30] B. Wasylyk,et al. The Ets family of transcription factors. , 1993, European journal of biochemistry.
[31] J. Massagué,et al. The transforming growth factor-beta family. , 1990, Annual review of cell biology.
[32] T. Libermann,et al. Downloaded from http://circres.ahajournals.org / by guest on February 20, 2013Role of the Ets Transcription Factors in the Regulation of , 2022 .